FOS and neuroblastoma: This is because behavioral evaluation was performed 20 min after drug administration, and IQM-PC332 has been shown to interfere with DREAM-mediated transcriptional repression of c-fos expression in STHdhQ7/7 neuroblastoma cells in just 15 min after drug exposure [20].